# Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery

> **NCT07027670** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 48 (actual)

## Conditions studied

- Cardiac Surgical Procedures
- Coronary Artery Bypass
- Aortic Valve Disease
- Mitral Valve Disease

## Interventions

- **DRUG:** 5-Aminolevulinic Acid hydrochloride (5-ALA)
- **OTHER:** Placebo
- **DRUG:** Sodium ferrous citrate (SFC)

## Key facts

- **NCT ID:** NCT07027670
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07027670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07027670, "Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07027670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*